Latest Funding And Capital Raising News

FFI Holdings Limited reported a remarkable 283.5% jump in net profit for FY2025, driven by property revaluations and operational growth, while raising $7.2 million to fund expansion in food manufacturing and property development.

Rhythm Biosciences has announced a $3.75 million placement to accelerate the commercial launch of its ColoSTAT® cancer detection test and expand its geneType™ product suite into key markets. The capital raise includes director participation and attaching options, pending shareholder approval.

Botala Energy has raised A$1.5 million through a discounted share placement to fund critical drilling and feasibility work at its Serowe CBM Project in Botswana. Directors and the CEO are backing the raise, signaling confidence in the project’s potential.

Orezone Gold Corporation reports solid Q2-2025 results from its Bomboré Gold Mine, maintaining production guidance and progressing major expansion projects on schedule and budget.

Silver Mines Limited has launched a $3 million Share Purchase Plan offering eligible shareholders in Australia and New Zealand the chance to buy shares at a 16.3% discount. The offer, which opened on 13 August 2025, supports key development and exploration projects.

AKORA Resources has launched a $2.91 million capital raising through a placement and entitlement offer to fund critical development milestones at its Bekisopa Iron Ore Project in Madagascar.

Macro Metals Limited has successfully raised A$2 million through a share placement, positioning itself to accelerate exploration and expand its mining services operations.

Horizon Gold has completed a major drilling campaign at its Gum Creek Gold Project, delivering high-grade gold intercepts and advancing its feasibility study on track for early 2026. A $12 million capital raise post-quarter end aims to fund further exploration and project development.

360 Capital Mortgage REIT has successfully raised $6.4 million through an additional placement of over one million new units, aiming to expand its mortgage loan portfolio and enhance trading liquidity.

Hazer Group has successfully raised $10.7 million through a combination of a share placement and a share purchase plan, positioning the company to advance its innovative clean hydrogen and graphite production technology.

Prescient Therapeutics has extended its Share Purchase Plan closing date to 22 July 2025, aiming to raise up to A$7 million to advance its targeted cancer therapy PTX-100 through Phase 2 clinical trials.

Spacetalk Ltd has raised $3 million through convertible notes from its largest shareholder and converted $1 million of secured debt, positioning the company for international growth and new product development.